Anna Lindblom
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 5%
- Parvovirus B19 Infection Studies
Papers in
-
- Parvovirus B19 Infection Studies 5
-
- Urinary Tract Infections Management 3
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Co-authors
- Kristina Broliden (9 shared papers)Thomas Tolfvenstam (7 shared papers)Oscar Norbeck (4 shared papers)Christina Åhrén (6 shared papers)Nahid Karami (5 shared papers)Bo Johansson (1 shared paper)Susann Wolf (1 shared paper)Angelia Chow (2 shared papers)
- Journals
- Clinical Infectious Diseases (2 papers)PLoS ONE (2 papers)Journal of Clinical Virology (2 papers)Scientific Reports (1 paper)Blood (1 paper)
- Partner nations
- SwedenUnited StatesSingapore
In The Last Decade
Anna Lindblom
19 papers receiving 513 citations
Peers
Comparison fields: 5 of 64
- Molecular Medicine 71
- Infectious Diseases 255
- Dermatology 119
- Endocrinology 49
- Applied Microbiology and Biotechnology 19
Countries citing papers authored by Anna Lindblom
This map shows the geographic impact of Anna Lindblom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lindblom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lindblom more than expected).
Fields of papers citing papers by Anna Lindblom
This network shows the impact of papers produced by Anna Lindblom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lindblom. The network helps show where Anna Lindblom may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Lindblom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 94 | |
| 2 | 2011 | 52 | |
| 3 | 2010 | 46 | |
| 4 | 2008 | 44 | |
| 5 | 2008 | 39 | |
| 6 | 2016 | 33 | |
| 7 | 2010 | 31 | |
| 8 | 2008 | 29 | |
| 9 | 2018 | 20 | |
| 10 | 2006 | 20 | |
| 11 | 2011 | 18 | |
| 12 | 2022 | 17 | |
| 13 | 2020 | 16 | |
| 14 | 2018 | 15 | |
| 15 | 2016 | 15 | |
| 16 | 2020 | 13 | |
| 17 | 2008 | 10 | |
| 18 | 2021 | 9 | |
| 19 | Recurrent infection with Extended-Spectrum Beta-Lactamase (ESBL) -producing Enterobacteriaceae | 2020 | 2 |
About Anna Lindblom
Anna Lindblom is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Endocrinology and Dermatology, having authored 19 papers that have together received 523 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Dermatological and COVID-19 studies (5 papers), Parvovirus B19 Infection Studies (5 papers), Enterobacteriaceae and Cronobacter Research (4 papers), Virus-based gene therapy research (3 papers), Urinary Tract Infections Management (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Prenatal Screening and Diagnostics (2 papers). The work is most often cited by research in Molecular Medicine (71 citations), Infectious Diseases (255 citations), Dermatology (119 citations), Endocrinology (49 citations) and Applied Microbiology and Biotechnology (19 citations). Anna Lindblom has collaborated with scholars based in Sweden, United States and Singapore. Frequent co-authors include Kristina Broliden, Thomas Tolfvenstam, Oscar Norbeck, Christina Åhrén, Nahid Karami, Bo Johansson, Susann Wolf, Angelia Chow, Eng Eong Ooi and Ling Ling. Their work appears in journals such as Clinical Infectious Diseases, PLoS ONE, Journal of Clinical Virology, Scientific Reports and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.